Response Biomedical Corp. (RPBIF)


OTC BB - OTC BB Delayed Price. Currency in USD
0.860.00 (0.00%)
As of 12:36 PM EDT. Market open.
People also watch:
RBM.TOREPRRSCFNNVCREMI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.00
Prev Close0.86
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52wk Range
1y Target EstN/A
Market Cap9.33M
P/E Ratio (ttm)-6.73
Beta1.05
Volume0
Avg Vol (3m)1,377
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Response Biomedical Corp. :RPBIF-US: Earnings Analysis: Q1, 2016 By the Numbers : June 9, 2016
    Capital Cube3 months ago

    Response Biomedical Corp. :RPBIF-US: Earnings Analysis: Q1, 2016 By the Numbers : June 9, 2016

    Click here to see latest analysisResponse Biomedical Corp. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Response Biomedical Corp. – Spectral Medical Inc, Quidel Corporation, Abbott Laboratories, Becton, Dickinson and Company, Meridian Bioscience, Inc. and Thermo Fisher Scientific Inc. (EDTXF-US, QDEL-US, ABT-US, BDX-US, VIVO-US […] (Read more...) The post Response Biomedical Corp. :RPBIF-US: Earnings Analysis: Q1, 2016 By the Numbers : June 9, 2016 appeared first on CapitalCube.

  • PR Newswire3 months ago

    TSX Delisting Review - Response Biomedical Corp. (Symbol: RBM)

    TORONTO, May 31, 2016 /CNW/ - DELISTING REVIEW Response Biomedical Corp. (the "Company") – Further to TSX Bulletin 2016-0389 dated April 18, 2016, TSX has decided to extend its review of the ...

  • CNW Group3 months ago

    TSX Delisting Review - Response Biomedical Corp. (Symbol: RBM)

    TSX Delisting Review - Response Biomedical Corp. (Symbol: RBM)